Werewolf Therapeutics HOWL
NASDAQ HOWL
$1.01 -0.02 (-1.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) FCF Margin (2022 - 2026)

Updated

Werewolf Therapeutics' FCF Margin came in at 31.57% for Q2 2026.

Analysis

Werewolf Therapeutics (HOWL) FCF Margin (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Werewolf Therapeutics reported FCF Margin of -143.56%, up 406203.10 percentage points year-over-year; for FY2024, it was -2970.63%, down 2803.25 percentage points from FY2023.

  • Going back by year, FCF Margin was -167.38% in FY2023 (+102.16 pp) and -269.54% in FY2022.
  • The Q2 2026 figure represents the highest quarterly FCF Margin in data going back to Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 33.76%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 25.03%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 18.33%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 26.96%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 38.60%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 6.55%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.70%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 44.00%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 2.01%
10 Werewolf Therapeutics 49.08 Mn -142.18 Mn - 31.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 31.57%
Dec 31, 2024 -95,833.33%
Jun 30, 2024 -1,241.82%
Mar 31, 2024 -2,076.55%
Dec 31, 2023 -318.65%
Sep 30, 2023 -125.98%
Jun 30, 2023 -137.40%
Mar 31, 2023 -225.49%
Dec 31, 2022 -170.09%
Sep 30, 2022 -330.50%
Jun 30, 2022 -34.09%
API Access

Werewolf Therapeutics FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=HOWL&period=max&api_key=YOUR_API_KEY